Arrowhead Pharmaceuticals to Host a Webinar on its Cardiometabolic Pipeline as Part I of the 2026 Summer Series of R&D Webinars
Arrowhead Pharmaceuticals announced the 2026 Summer Series of R&D webinars, kicking off with Part I focused on its cardiometabolic pipeline on June 29, 2026. The event will feature presentations from Arrowhead management and Dr. Steven Nissen of the Cleveland Clinic, covering the treatment landscape and assets such as Plozasiran, Zodasiran, and ARO-DIMER-PA.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.